File: bbe24bvw4_pub_de.pdfTrial reference: A phase 3 multinational, open-label, systemic gene delivery study to evaluate the safety and efficacy of SRP-9003 in subjects with limb girdle muscular dystrophy 2E/R4Doc type: Information for the public
